Conference Coverage
Conference Coverage
11/05/2024

Joseph Kvedar, MD

Joseph Kvedar, MD
Dr Kvedar provides a preview of his session, "Perspectives on Virtual Care in Primary Care" at PUPC 2024. In this session, Dr Kvedar will review the modalities for providing virtual care, some friction...
11/05/2024
Research Summary
Research Summary
08/23/2024
Anthony Calabro, MA
Researchers examined the efficacy of allogeneic adipose-derived mesenchymal stem cell injections into the lacrimal gland for treating dry eye disease in patients with Sjögren syndrome.
08/23/2024
FDA Alert
FDA Alert
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
Roundtable Wrap-Up
Roundtable Wrap-Up
07/19/2024
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing patients with diabetes and the value of utilizing the services of a...
07/19/2024
Conference Coverage
Conference Coverage
07/16/2024

Randall Hudspeth, PhD, MBA, MS, APRN-CNP, FRE, FAANP

Randall Hudspeth, PhD, MBA, MS, ...
Although more patients are seeking pain relief in primary care settings, practitioners may not have the experience in managing and treating patients with complex pain situations or may not be familiar with...
07/16/2024
Research Summary
Research Summary
07/15/2024
Anthony Calabro, MA
Researchers compared clinical characteristics, health care costs, and mortality outcomes among patients with Alzheimer dementia with and without agitation.
07/15/2024
covid-19 roundup
covid-19 roundup
06/26/2024
Anthony Calabro, MA
In this COVID-19 roundup, researchers report on an increase in outpatient care following COVID-19 infection, cognition and memory impairment among those recovering from COVID-19, and more.
06/26/2024
research summary
research summary
03/11/2024

Leigh Precopio

Leigh Precopio
Researchers examined how the availability of mental health services and patient specific characteristics impacted levels of anxiety and depression in residents of long-term care settings following COVID-19...
03/11/2024
FDA Alert
FDA Alert
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
Roundtable Wrap-Up
Roundtable Wrap-Up
09/05/2023
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the evaluation, treatment, and management of patients with moderate-to-severe atopic dermatitis.
09/05/2023